Citation Impact

Citing Papers

Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
2010 StandoutScience
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Endothelin Peptides: Biological Activities, Cellular Signalling and Clinical Significance
1992
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein
2003
Atrial natriuretic factor modifies bile flow and composition in the rat
1993
Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin
1991
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
2004
Alzheimer's disease
2011 Standout
The role of biological markers in the early and differential diagnosis of Alzheimer’s disease
2002
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
2009 Standout
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Brain natriuretic peptide is a novel cardiac hormone
1989
Obesity, diabetes and the central nervous system
1998
Conditional Forebrain Inactivation of Nicastrin Causes Progressive Memory Impairment and Age-Related Neurodegeneration
2009 StandoutNobel
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
2008 Standout
CSF markers for incipient Alzheimer's disease
2003
Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease
2003
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
2009
Anomalously phosphorylated tau and Aβ fragments in the CSF correlates with cognitive impairment in MCI subjects
2005
Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide
2001 StandoutNobel
Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
2002
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Tau phosphorylation: physiological and pathological consequences
2004
Ghrelin induces adiposity in rodents
2000 StandoutNature
Alzheimer's disease
2015
Central nervous system control of food intake
2000 StandoutNature
Atrial Natriuretic Factor: Implications for Cardiac Pacing and Electrophysiology
1994
Combined Analysis of CSF Tau Levels and [123I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer’s Disease
2002
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
2010
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
2010
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
2006 Standout
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Post-translational modifications of tau protein in Alzheimer’s disease
2004
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
2004
The Amyloid State of Proteins in Human Diseases
2012 Standout
Proteasomal degradation of tau protein
2002
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
A 6-day intracerebroventricular infusion of the growth hormone-releasing peptide KP-102 stimulates food intake in both non-stressed and intermittently-stressed rats
2000
Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231
2002
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
2007
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
2012 Standout
Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase
1987 StandoutNobel
Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: Guanylate cyclase-linked and cyclase-free receptors
1987
The Transcriptional Program in the Response of Human Fibroblasts to Serum
1999 StandoutScience
ANF stimulation of detergent‐dispersed particulate guanylate cyclase from bovine adrenal cortex
1986
Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion
1987
Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells.
1986 StandoutNobel
Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
2013
3D structure of Alzheimer's amyloid-β(1–42) fibrils
2005 Standout
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA.
1990
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
2007
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.
1988
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
2005 StandoutScience
Stoichiometric analysis of internalization, recycling, and redistribution of photoaffinity-labeled guanylate cyclase/atrial natriuretic factor receptors in cultured murine Leydig tumor cells.
1993
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Purification and subunit composition of atrial natriuretic peptide receptor.
1987
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Solubilization of guanylyl cyclase from bovine rod outer segments and effects of lowering Ca2+ and nitro compounds
1991 StandoutNobel
Plasma tau in Alzheimer disease
2016 StandoutNobel
Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
1988 StandoutNobel
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
1999 StandoutNobel
The Caenorhabditis elegans IMPAS gene, imp-2, is essential for development and is functionally distinct from related presenilins
2004 StandoutNobel
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Biological Markers in Alzheimer Disease
2002
Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung.
1986 StandoutNobel
Purification of atrial natriuretic peptide receptor from bovine lung. Evidence for a disulfide-linked subunit structure.
1987
Two distinct forms of receptors for atrial natriuretic factor in bovine adrenocortical cells. Purification, ligand binding, and peptide mapping.
1987
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
2000 StandoutScience
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
1994 Standout
Atrial natriuretic factor receptor on cultured Leydig tumor cells: ligand binding and photoaffinity labeling
1986

Works of Hideto Ohno being referenced

Endothelin Family in Human Plasma and Cerebrospinal Fluid
1990
Increased Levels of β-Human Atrial Natriuretic Peptide-like Immunoreactivity in Chronically Overloaded Atrial Tissue
1990
The effects of chronic central administration of corticortrop in-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones
1991
Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
1999
Large‐scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease
2001
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease
2004
CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study
2000
Solubilization and molecular weight estimation of atrial natriuretic factor receptor from bovine adrenal cortex
1985
Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in concious rats
1986
Rankless by CCL
2026